Successful Hemophilia B Gene Therapy In Dogs May Justify Human Experiments

CHAPEL HILL - Using gene therapy on experimental animals, researchers at the University of North Carolina at Chapel Hill and elsewhere have partially corrected the protein deficiency responsible for hemophilia B. The inherited illness, also known as Christmas disease, causes victims to bleed spontaneously, live severely restricted lives and often die prematurely.

Tests have shown that a unique strain of North Carolina hemophiliac dogs injected with corrected genes produced the blood clotting protein known as factor IX and are continuing to produce it steadily more than a year and a half after treatment, scientists say. Not making the clotting factor is what causes people and animals with the condition to bleed.

"The correction is modest, about 1 percent, but we believe that's enough to justify consideration of clinical trials in humans," said Dr. Timothy C. Nichols, associate professor of medicine and pathology at the UNC-CH School of Medicine. "This level of correction in humans could be enough to improve certain people with severe hemophilia, who bleed spontaneously, to the point where they would only bleed when injured. That would be a major improvement."

Two reports on the research appear in the Jan. 5 issue of Nature Medicine. Besides UNC-CH, other institutions involved include the universities of Pennsylvania and Washington at Seattle, Stanford University and biotechnology companies Avigen Inc. and Cell Genesys Inc. of Alameda and Foster City, Calif., respectively.

The dogs, which inherit hemophilia naturally just as humans do and have been bred for a half century at UNC-CH's Frances Owen Blood Research Laboratory, showed a dose response, Nichols said. That is, the more corrected gene they received, the more strongly their bodies responded. They tolerated the treatment and replacement therapy well.

"This dose response should identify the appropriate initial dose for use in humans," he

Contact: David Williamson
University of North Carolina at Chapel Hill

Page: 1 2 3

Related biology news :

1. Successful progress launch paves the way for further scientific utilisation of the ISS by Europe
2. Successful Green Solvent Found For Problematic Chemicals
3. University Of Pittsburgh Involved In First Successful Example Of Gene Therapy For Pain Control
4. News Backgrounder: Duke Primate Center Successfully Fosters Mysterious Aye-Ayes
5. Successful Specialist Care For Cystic Fibrosis Patients From Childhood To Adulthood
6. New Treatment Successful With Hepatitis C
7. New RNA Repair May Lead To More Successful Gene Therapy
8. NIAID Doctor Successfully Treats Longest Case Of Malaria Infection On Record
9. Chlamydia Testing Of Urine Samples Can Be Successful
10. Hemophilia therapy update: New information on investigational Factor VIII therapy development
11. Hemophilia trials, other studies may herald successful gene therapies for human diseases

Post Your Comments:

(Date:7/10/2020)... ... July 08, 2020 , ... Overcoming Comparability Issues in ... FDAnews Webinar, Wednesday, July 22, 2020 • 1:30 p.m.-3:00 p.m. EDT, https://www.fdanews.com/cellandgenetherapy ... most effective way to complete one? Will the study comply with all FDA ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. ... of Neihulizumab, a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), ... Dr. Paul J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, ...
(Date:7/1/2020)... ... 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit research ... adult brain cancer—announced today the appointments of its first Senior Fellows: John Boockvar, ... organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; they ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... Anomet ... to three different materials for use with CRM, neurostimulation, vascular, and related devices. ... to meet specific design requirements, performance, and cost criteria; especially where solid wire ...
(Date:7/22/2020)... ... ... Join experts from Reed Tech , Gary Saner, Sr. Manager, Information Solutions Life ... webinar on Thursday, August 13, 2020 at 11am EDT (4pm BST/UK). , The ... medical devices, the NMPA has departments dealing with medical device registration (pre-market approvals) and ...
(Date:7/10/2020)... ... July 08, 2020 , ... Bode Technology, ... expansion of laboratory operations through its COVID-19 testing service, Bode-CARES . Bode-CARES ... , Bode-CARES provides a turnkey solution that includes a comprehensive collection ...
(Date:7/7/2020)... ... , ... Bio-IT World has announced the winners of the ... of Chicago, Massachusetts General Hospital, Mission: Cure, and the Pistoia Alliance were honored. ... examples of how technology innovations and strategic initiatives can be powerful forces for ...
Breaking Biology Technology:
Cached News: